Tenaya Therapeutics CEO to present at Cell & Gene Meeting

By The Science Advisory Board staff writers

October 12, 2021 -- Faraz Ali, CEO of biotechnology firm Tenaya Therapeutics, will present on October 13 at 3:15 p.m. PT as part of a panel discussion at the Cell & Gene Meeting on the Mesa in Carlsbad, CA.

Ali will participate in the session titled, "Personalizing Cardiovascular Therapies to Address the Underlying Causes of Disease." The panel will discuss cell and gene therapies in cardiovascular medicine. Tenaya Therapeutics will also have a company presentation at 4:45 p.m. PT on October 13.

Tenaya Therapeutics develops gene therapies for rare genetic disorders and for more prevalent heart conditions through three product platforms: gene therapy, cellular regeneration, and precision medicine.

Meeting on the Mesa ramps up rules on COVID-19 vaccination, testing
The Alliance for Regenerative Medicine has implemented new rules for its Cell & Gene Meeting on the Mesa, which is scheduled for October 12-14, 2021,...

Copyright © 2021 scienceboard.net


Conferences
Building Biology in 3D Hybrid Symposium
October 26-27
La Jolla, California United States
Northeast Regional Laboratory Staff and Core Directors (NERLSCD) 2021
November 3-5
Portsmouth, New Hampshire United States
CPhI Worldwide 2021
November 9-11
Milan, Lombardia Italy
Society for Immunotherapy of Cancer (SITC) Annual Meeting
November 10-14
Washington, DC, District of Columbia United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter